(c) REPORT.—As a condition on receipt of a grant 
or cooperative agreement under this section, a State, local, 
or tribal government shall agree to prepare and submit, 
not later than 90 days after the end of the grant or coop-
erative agreement period, a report to the Director describ-
ing the results of the activities supported through the 
grant or cooperative agreement. 
(d) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of the fiscal years 2010 and 2011, 
and such sums as may be necessary for each of the fiscal 
years 2012 through 2014. 
SEC. 6. REDUCING OVERDOSE DEATHS. 
(a) IN GENERAL.—Not later than 180 days after the 
date of the enactment of this Act, the Director of the Cen-
ters for Disease Control and Prevention shall develop a 
plan in consultation with a task force comprised of stake-
holders to reduce the number of deaths occurring from 
overdoses of drugs and shall submit the plan to Congress. 
The plan shall include— 
(1) an identification of the barriers to obtaining 
accurate data regarding the number of deaths occur-
ring from overdoses of drugs; 
VerDate Nov 24 2008 
05:02 Jun 13, 2009
Jkt 079200
PO 00000
Frm 00009
Fmt 6652
Sfmt 6201
E:\BILLS\H2855.IH
H2855
smartinez on PROD1PC64 with BILLS
(2) an identification of the barriers to imple-
menting more effective overdose prevention strate-
gies and programs; 
(3) an examination of overdose prevention best 
practices; 
(4) an analysis of the supply source of drugs 
that caused both fatal and nonfatal unintentional 
poisonings; 
(5) recommendations for improving and ex-
panding overdose prevention programming; and 
(6) recommendations for such legislative or ad-
ministrative action as the Director considers appro-
priate. 
(b) DEFINITION.—In this section, the term ‘‘stake-
holder’’ means any individual directly impacted by drug 
overdose, any direct service provider who engages individ-
uals at-risk of a drug overdose, any drug overdose preven-
tion advocate, the National Institute on Drug Abuse, the 
Center for Substance Abuse Treatment, the Centers for 
Disease Control and Prevention, the Food and Drug Ad-
ministration, and any other individual or entity with drug 
overdose expertise. 
SEC. 7. OVERDOSE PREVENTION RESEARCH. 
(a) OVERDOSE RESEARCH.—The Director of the Na-
tional Institute on Drug Abuse shall prioritize and conduct 
VerDate Nov 24 2008 
05:02 Jun 13, 2009
Jkt 079200
PO 00000
Frm 00010
Fmt 6652
Sfmt 6201
E:\BILLS\H2855.IH
H2855
smartinez on PROD1PC64 with BILLS
or support research on drug overdose and overdose preven-
tion. The primary aims of this research shall include— 
(1) examinations of circumstances that contrib-
uted to drug overdose and identification of drugs as-
sociated with fatal overdose; 
(2) evaluations of existing overdose prevention 
program intervention methods; and 
(3) pilot programs or research trials on new 
overdose prevention strategies or programs that have 
not been studied in the United States. 
(b) DOSAGE FORMS OF NALOXONE.—The Director 
of the National Institute on Drug Abuse shall support re-
search on the development of dosage forms of naloxone 
specifically intended to be used by lay persons or first re-
sponders for the prehospital treatment of unintentional 
drug overdose. 
(c) AUTHORIZATION
OF APPROPRIATIONS.—There 
are authorized to be appropriated to carry out this section 
$5,000,000 for each of the fiscal years 2010 and 2011, 
and such sums as may be necessary for each of the fiscal 
years 2012 through 2014. 
SEC. 8. DEFINITIONS. 
In this Act: 
VerDate Nov 24 2008 
05:02 Jun 13, 2009
Jkt 079200
PO 00000
Frm 00011
Fmt 6652
Sfmt 6201
E:\BILLS\H2855.IH
H2855
smartinez on PROD1PC64 with BILLS
(1) DIRECTOR.—Unless otherwise specified, the 
term ‘‘Director’’ means the Director of the Centers 
for Disease Control and Prevention. 
(2) DRUG.—The term ‘‘drug’’— 
(A) means a drug (as that term is defined 
in section 201 of the Federal Food, Drug, or 
Cosmetic Act (21 U.S.C. 321)); and 
(B) includes any controlled substance (as 
that term is defined in section 102 of the Con-
trolled Substances Act (21 U.S.C. 802)). 
(3) ELIGIBLE ENTITY.—The term ‘‘eligible enti-
ty’’ means an entity that is a State, local, or tribal 
government, a correctional institution, a law enforce-
ment agency, a community agency, or a private non-
profit organization. 
(4) STATE.—The term ‘‘State’’ means any of 
the several States, the District of Columbia, Puerto 
Rico, the Northern Mariana Islands, the Virgin Is-
lands, Guam, American Samoa, and any other terri-
tory or possession of the United States. 
(5) TRAINING.—The term ‘‘training’’ means 
any activity that is educational, instructional, or 
consultative in nature, and may include volunteer 
trainings, awareness building exercises, outreach to 
VerDate Nov 24 2008 
19:18 Jun 13, 2009
Jkt 079200
PO 00000
Frm 00012
Fmt 6652
Sfmt 6201
E:\BILLS\H2855.IH
H2855
smartinez on PROD1PC64 with BILLS
individuals who are at-risk of a drug overdose, and 
distribution of educational materials. 
Æ 
VerDate Nov 24 2008 
05:02 Jun 13, 2009
Jkt 079200
PO 00000
Frm 00013
Fmt 6652
Sfmt 6301
E:\BILLS\H2855.IH
H2855
smartinez on PROD1PC64 with BILLS